Home
Conditions
Lupus Erythematosus, Systemic

Clinical trial condition

Lupus Erythematosus, Systemic

Explore clinical trials studying Lupus Erythematosus, Systemic. Study availability and eligibility vary by location and protocol.

840 public trials 219 recruiting studies

Refine in advanced search Browse all conditions

Lupus Erythematosus, Systemic trial results

Recruiting

Research Accelerated by You Lupus Registry

NCT06927219

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Cutaneous Lupus Erythematosus (CLE), +16 more
Locations: Online Registry - No Physical Site Required Washington D.C., District of Columbia, United States

View Trial Details

Recruiting

Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases

NCT07361094

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +36 more
Locations: Beijing GoBroad Boren Hospital Beijing, China

View Trial Details

Recruiting

Immune Profiling of Refractory cSLE Exposed to CD3×CD19 BiTE

NCT07352332

Conditions: Autoimmune Diseases, Childhood-onset Systemic Lupus Erythematosus, Connective Tissue Diseases, +3 more
Locations: Children's Hospital, Zhejiang University School of Medicine Hangzhou, China

View Trial Details

Recruiting

CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases

NCT07315087

Conditions: ANCA Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +15 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, China

View Trial Details

Recruiting

HLA Antibodies in Systemic Lupus Erythematosus

NCT06921239

Conditions: Autoimmune Diseases, Connective Tissue Diseases, HLA Antibodies, +4 more
Locations: CHRU Amiens Amiens, France

View Trial Details

Recruiting

the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune Diseases

NCT07339540

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +25 more
Locations: Tongji Hospital, Affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Recruiting

A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Dynamics of Universal CD19 / 20 Car-t Cell Injection in Moderate to Severe Refractory Systemic Lupus Erythematosus

NCT07339332

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations: Wuhan Union Hospita Wuhan, Hubei, China

View Trial Details

Recruiting

Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE

NCT07331467

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations: Affiliated Drum Tower Hospital, Medical School of Nanjing University Nanjing, Jiangsu, China

View Trial Details

Recruiting

Maternal Autoimmune Disease Research Alliance (MADRA) Registry

NCT03276923

Conditions: Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +23 more
Locations: Duke University Durham, North Carolina, United States

View Trial Details

Recruiting

Duke Lupus Registry

NCT00512694

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Cutaneous Lupus, +4 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Lupus Erythematosus, Systemic

Lupus Erythematosus, Systemic trial results

Related conditions